iSpecimen Inc.

ISPC

US45032V1089

Software

Market Closed - Nasdaq Other stock markets 21:00:00 16/07/2024 BST			5-day change	1st Jan Change
0.3055 ^USD	+7.34%		+12.73%	-38.97%

07-08	ISpecimen Inc. Announces Resignation of Benjamin Bielak as Chief Information Officer and Secretary, Effective July 15, 2024	CI
06-03	Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May	MT

ISpecimen Inc. Announces Resignation of Benjamin Bielak as Chief Information Officer and Secretary, Effective July 15, 2024

July 08, 2024 at 10:00 pm

On July 5, 2024, iSpecimen Inc. received written notice from Benjamin Bielak that he will be resigning as Chief Information Officer and Secretary of the Company, effective July 15, 2024.

Latest news about iSpecimen Inc.

ISpecimen Inc. Announces Resignation of Benjamin Bielak as Chief Information Officer and Secretary, Effective July 15, 2024	07-08	CI
Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May	06-03	MT
Top Premarket Decliners	06-03	MT
Transcript : ISpecimen Inc., Q1 2024 Earnings Call, May 07, 2024	05-07
Earnings Flash (ISPC) ISPECIMEN Reports Q1 Revenue $2.3M	05-07	MT
ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
ISpecimen Inc. Announces the Board Changes	03-26	CI
Transcript : ISpecimen Inc., 2023 Earnings Call, Mar 14, 2024	03-14
ISpecimen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-13	CI
ISpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research	01-23	CI
Ispecimen Inc. Announces Executive Changes	12-21	CI
Transcript : ISpecimen Inc., Q3 2023 Earnings Call, Nov 02, 2023	11-02
Earnings Flash (ISPC) ISPECIMEN Posts Q3 Revenue $2.8M	11-02	MT
ISpecimen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-02	CI
ISpecimen Inc. Provides Revenue Guidance for Third Quarter 2023	23/10/23	CI
ISpecimen Inc. Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers	28/09/23	CI
Ispecimen Expands Provider Network to Enhance Support for Women's Health Research	13/09/23	CI
ISpecimen to Reduce Headcount by 20% as Part of Restructuring	06/09/23	MT
ISpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers	16/08/23	CI
Transcript : ISpecimen Inc., Q2 2023 Earnings Call, Aug 02, 2023	02/08/23
Earnings Flash (ISPC) ISPECIMEN Posts Q2 Revenue $1.6M, vs. Street Est of $3.1M	02/08/23	MT
ISpecimen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	02/08/23	CI
ISpecimen Inc. Receives A Letter of Resignation from Christopher Ianelli to Resign as A Director	07/07/23	CI
ISpecimen Inc.Â Adds Thirteen New Biospecimen Suppliers to its Proprietary Marketplace Throughout the First Half of 2023	06/07/23	CI
Earnings Flash (ISPC) ISPECIMEN Reports Q1 Revenue $3M, vs. Street Est of $2.6M	04/05/23	MT

iSpecimen Inc. is a technology-driven company. The Company's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The Company's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Companyâs platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.

Sector

Software

Calendar

31/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for iSpecimen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.3055 USD

Average target price

3 USD

Spread / Average Target

+882.00%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

	1st Jan change	Capi.
ISPECIMEN INC.	-38.97%	3.71M
MICROSOFT CORPORATION	+19.54%	3,374B
CADENCE DESIGN SYSTEMS, INC.	+14.45%	86.53B
PALANTIR TECHNOLOGIES INC.	+66.98%	63.85B
DASSAULT SYSTÈMES SE	-22.93%	49.62B
THE TRADE DESK, INC.	+40.29%	48.96B
ATLASSIAN CORPORATION	-22.99%	46.84B
SEA LIMITED	+75.85%	41.28B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-4.26%	26.83B
ROBLOX CORPORATION	-9.71%	26.31B

Other Software

iSpecimen Inc.

Equities

ISPC

US45032V1089

Software

ISpecimen Inc. Announces Resignation of Benjamin Bielak as Chief Information Officer and Secretary, Effective July 15, 2024

Latest news about iSpecimen Inc.

Chart iSpecimen Inc.

Company Profile

Income Statement Evolution

Ratings for iSpecimen Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Software